A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma
2009 ◽
Vol 100
(1)
◽
pp. 28-36
◽
A Rocca
◽
S Minucci
◽
G Tosti
◽
D Croci
◽
F Contegno
◽
...
2006 ◽
Vol 4
(12)
◽
pp. 92
A. Daud
◽
J.L. Gump
◽
A. Neuger
◽
R.H. DeConti
◽
S. Bastine
◽
...
2018 ◽
Vol 10
(2)
◽
pp. 53
◽
Varun Monga
◽
Umang Swami
◽
Munir Tanas
◽
Aaron Bossler
◽
Sarah L. Mott
◽
...
2009 ◽
Vol 15
(7)
◽
pp. 2479-2487
◽
Adil I. Daud
◽
Jana Dawson
◽
Ronald C. DeConti
◽
Elona Bicaku
◽
Douglas Marchion
◽
...
2014 ◽
Vol 73
(3)
◽
pp. 495-501
◽
Jennifer J. Wheler
◽
Filip Janku
◽
Gerald S. Falchook
◽
Tiffiny L. Jackson
◽
Siqing Fu
◽
...
2009 ◽
Vol 15
(7)
◽
pp. 2488-2496
◽
Pamela Munster
◽
Douglas Marchion
◽
Elona Bicaku
◽
Mira Lacevic
◽
Jongphil Kim
◽
...
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3084-3084
◽
P. N. Munster
◽
D. C. Marchion
◽
E. Bicaku
◽
P. Sullivan
◽
C. Beam
◽
...
2007 ◽
Vol 92
(4)
◽
pp. 542-545
◽
G. Bug
◽
K. Schwarz
◽
C. Schoch
◽
M. Kampfmann
◽
R. Henschler
◽
...
2013 ◽
Vol 19
(15)
◽
pp. 4262-4272
◽
Balaji Venugopal
◽
Richard Baird
◽
Rebecca S. Kristeleit
◽
Ruth Plummer
◽
Richard Cowan
◽
...
2013 ◽
Vol 751
(1)
◽
pp. 19-26
◽
T. Ahmad
◽
K. Shekh
◽
S. Khan
◽
A. Vikram
◽
L. Yadav
◽
...